# Human Immunoglobulin

## Human Immunoglobulin 3gm/50mL

| TAH Drug Code      | [IIG3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IIG3)                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Replacement IgG therapy in primary immunodeficiency, myeloma & chronic lymphatic leukamia with severe secondary hypogammaglobulinemia & recurrent infections, congenital or AIDS with recurrent infections. Immunomodulatory therapy in idiopathic thrombocytopenic purpura (ITP) in adults or children at high risk of bleeding or prior to surgery, allogeneic bone marrow transplantation, Kawasaki disease.          |
| Dosing             | IVD, Replacement therapy 0.2-0.6 g/kg/month as a single dose or 2 divided doses at fortnightly intervals. Idiopathic Thrombocytopenic Purpura (ITP) Up to max total cumulative dose of 2 g/kg over 2-5 days. Kawasaki disease 1.6-2 g/kg in divided doses over 2-5 days or 2 g/kg as single dose. Allogeneic bone marrow transplantation Initially 0.5 g/kg/week. Guillain Barre Syndrome (GBS) 0.4 g/kg/day for 5 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | - Patients who have a true allergic reaction to human immunoglobulin. - Patients with IgA deficiency who have antibodies against IgA, as well as patients with a history of allergies. - Patients with a history of allergy to the excipient maltose.                                                                                                                                                                    |
| Adverse Effects    | Malaise, abdominal pain, headache, chest tightness, facial flushing or pallor, erythema, hot sensations, dyspnea or respiratory difficulty, non-urticarial skin rash, cutaneous vasculitis, pompholyx on hands/palms, itching, tissue swelling, change in BP, nausea, vomiting.                                                                                                                                          |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/immune-globulin-intravenous-subcutaneous-and-intramuscular-drug-information)                                                                                                                                                                                                                                                                                                |

